Bayesian Capital Management’s MINDBODY, Inc. Class A Common Stock MB Stock Holding History

Bayesian Capital Management’s Portfolio MB Stock Details MB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,159	Closed	-$401K	–	917
2017 Q4	$401K	Buy	+13,159	New	+$405K	0.08%	364
2017 Q1	–	Sell	-16,668	Closed	-$355K	–	797
2016 Q4	$355K	Buy	+16,668	New	+$337K	0.09%	385

Other funds holding MB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

IVMX

Institutional Venture Management XIII Menlo Park, California $54.2M AUM 12.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bayesian Capital Management's MB Position: Q1 2018 in Review

Bayesian Capital Management sold out of MINDBODY, Inc. Class A Common Stock (MB) in Q1 2018, closing a stake of 13,159 shares — an estimated $401K sold.

Bayesian Capital Management first reported a position in MB in Q4 2016 and held it in 2 quarters. The position peaked at $401K in Q4 2017. 150 funds tracked by Wall St. Rank hold MB as of Q1 2018.

Bayesian Capital Management reported no remaining MINDBODY, Inc. Class A Common Stock position as of Q1 2018 after selling out during the quarter.
Bayesian Capital Management sold 13,159 MINDBODY, Inc. Class A Common Stock shares in Q1 2018, an estimated $401K.
Bayesian Capital Management first reported a position in MINDBODY, Inc. Class A Common Stock in Q4 2016 and held it in 2 quarters.
Bayesian Capital Management's MINDBODY, Inc. Class A Common Stock position peaked at $401K in Q4 2017.
150 funds tracked by Wall St. Rank held MINDBODY, Inc. Class A Common Stock as of Q1 2018.

Based on Bayesian Capital Management's 13F filing for Q1 2018, filed 15 May 2018.